China Animal Husbandry and Veterinary Medicine ›› 2022, Vol. 49 ›› Issue (2): 791-799.doi: 10.16431/j.cnki.1671-7236.2022.02.042

• Clinical Veterinary Medicine • Previous Articles    

Research Progress on Therapeutic Mechanism and Application of Canine Hematopoietic Stem Cell Transplantation

TIAN Yangqing, WANG Yayuan, ANG Yanfen, YAN Han, LIU Xin, YAN Yulin   

  1. College of Veterinary Medicine, Yunnan Agricultural University, Kunming 650201, China
  • Received:2021-07-26 Online:2022-02-05 Published:2022-01-27

Abstract: Hematopoietic stem cells (HSCs) are located at the top of the hematopoietic system, they are the only cells that have pluripotency and self-renewal ability in the hematopoietic system.They can differentiate into blood cells with various functions to maintain the establishment and dynamic balance of the blood system, which were the most thoroughly studied adult stem cells with the most mature clinical application.These important characteristics of hematopoietic stem cells have made great progress in the study of disease treatment mechanisms and clinical applications based on hematopoietic stem cells.Regenerative medicine treatment based on hematopoietic stem cells is currently the first choice for the treatment of hematological malignancies and genetic diseases, such as treatment of canine leukocyte adhesion defect syndrome, canine hereditary anemia, canine lymphoma, canine leukopenia, canine X-linked severe combined immunodeficiency using HSCs, etc., but due to the scarcity of leukocyte antigen-matched donors and the limited number of available hematopoietic stem cells, it cannot meet clinical needs.Therefore, how to obtain hematopoietic stem cells to meet clinical needs through in vitro culture has become a hot issue for scholars in recent years.With reference to existing research results, the authors systematically described the sources, in vitro isolation and culture, and treatment mechanism of hematopoietic stem cells, and summarized the clinical research of hematopoietic stem cell transplantation in the treatment of hereditary hemolytic anemia, leukocyte adhesion deficiency syndrome, lymphoma, leukopenia and X-linked severe combined immunodeficiency disease, in order to provide references for the wide application of hematopoietic stem cells in clinical treatment in the future.

Key words: dog; hematopoietic stem cells; transplantation; in vitro expansion; homing

CLC Number: